COVID-19 and Your Well being

0
33

Strongest and Most Constant Proof Most cancers Systematic Evaluation [6]Cohort Examine [7,8]Case Sequence [9] Continual kidney illness Case Sequence [10, 11, 12]Cohort Research [13, 14, 15] COPD Meta Analyses [4, 16]Case Sequence [17]Cohort Examine [14] Coronary heart situations, equivalent to coronary heart failure, coronary artery illness, or cardiomyopathies Cohort Examine [1, 2]Meta Analyses [3, 4]Case Sequence [5] Weight problems (BMI> 30 kg/m2) Cohort Research [18, 19, 20, 21, 22]Cross-sectional [23] Extreme Weight problems (BMI ≥ 40 kg/m2) Cohort Examine [98, 99]Cross-Sectional Examine [95]Meta Evaluation [107] Being pregnant Systematic Evaluation [54, 116]Case Management Examine [55]Case Sequence [56, 57, 58, 59]Cohort Examine [60, 61, 62, 117] Sickle cell illness Case Sequence [24, 25, 26, 27, 28] Smoking Meta Analyses [3, 16*, 63, 64, 65, 66, 101, 102, 104, 105] Strong organ transplantation Case Sequence [12, 29, 30, 31, 32, 33, 34]Meta Evaluation [100] Sort 2 diabetes mellitus Case Sequence [11]Longitudinal Examine [35]Cohort Examine [36, 37]Meta Evaluation [38]Cross-Sectional Examine [114] Blended Proof Bronchial asthma Cohort Examine [14, 39, 40, 41]Case Sequence [17] Cerebrovascular illness Meta Evaluation [42, 43, 44, 45]Synthesis of Proof [46]Cohort Examine [1, 2, 47, 48, 49] Hypertension Cohort Examine [1, 2, 49, 50, 51, 91, 93]Case Sequence [92]Systematic Evaluation [52]Meta Analyses [3, 4, 53, 94] Use of corticosteroids or different immunosuppressive medicines Case Sequence [67, 68, 69]Cohort Examine [70, 71] Restricted Proof Bone marrow transplantation Evaluation [72] HIV Case Sequence [73, 74]Cohort Examine [109, 110, 111, 112] Immune deficiencies Case Sequence [75]Systematic Evaluation [76] Inherited metabolic issues Cohort Examine [47, 77] Liver illness Meta-Evaluation [78]Cohort  Examine [79, 80, 118, 119]Literature Evaluation [81]Case Management Examine [120] Neurologic situations Cross-Sectional Examine [82]Cohort Examine [41, 49, 77] Different power lung illnesses Meta-Evaluation [4]Case Sequence [17]Cohort Examine [14, 83] Chubby (BMI > 25 kg/m2, however < 30 kg/m2) Cohort Examine [96, 106]Case Sequence [97]Meta Evaluation [115] Pediatrics Systematic Evaluation [84, 85]Cross-Sectional Examine [82, 86, 107]Cohort Examine [77, 87, 88, 103, 108, 113,121, 122, 125]Case Sequence [123, 124] Thalassemia Case Sequence [89]Cross-Sectional Examine [90] Sort 1 diabetes mellitus Case Sequence [11]Cohort Examine [36, 37]Meta-Evaluation [38]Cross-Sectional Examine [114]

Supply hyperlink